Lantheus Medical Imaging, Inc.
Please visit us at Booth #722
Lantheus Medical Imaging www.lantheus.com, a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, is headquartered in North Billerica, Massachusetts with offices in Canada and Puerto Rico.
In January 2013, LEU TechneLite® became the first Tc-99m generator in the United States that contains at least 95 percent non-HEU-sourced Mo-99 and meets the Centers for Medicare and Medicaid Services (CMS) criteria for the incremental add-on Hospital Outpatient Prospective Payment System (HOPPS) payment.
Lantheus has developed a world class, globally diversified and balanced supply chain for the procurement of Molybdenum-99 (Mo-99). The company receives Mo-99 from three of the four major processors and five of the six associated reactors.
Key Nuclear Medicine Products
TechneLite® (Technetium Tc99m Generator)
Xenon 133 (Xenon Xe133 Gas)
NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection)
QUADRAMET® (Samarium SM 153 Lexidronam Injection)